Covid-19 Vaccines Are Highly Effective For Pregnant Women And Their Babies

Corona Vaccine: The Covid-19 vaccine is extremely effective in producing antibodies in pregnant women. Protective immunity from the mother is also passed from breast milk to newborns. The research has been claimed in the American Journal of Obstetrics and Gynecology.

Big exposure of Covid-19 being very effective

Researchers found that vaccine-induced anti-body was equivalent in pregnant and lactating women compared to non-pregnant women. The researchers included 131 women of reproductive age as participants for the research, and among them 84 pregnant, 31 lactating and 16 women were not pregnant.

All women were vaccinated with Pfizer / BioNotech or Moderna. Vaccination of women was done either during pregnancy or after birth. Their ability to produce virus-specific antibodies was then combated with women who had been dosed but not pregnant.

The results showed that anti-body levels were found to be equal in all three groups and side-effects after vaccination were rare. Major discoveries have been made by researchers at Massachusetts General Hospital, Brigham & Women's Hospital and Regan Institute of MGH, MIT and Harvard. The effect of the vaccine in pregnant women is very encouraging, said Andrew Adlow, a medicine specialist and senior author of research at MGH.

Research conducted on pregnant women and their children

Although the small number of women involved in the research is a limited factor, it nevertheless gives very important early information on the effectiveness and safety of covid-19 vaccination in pregnancy. It matters, because new infectious diseases come with all the dangers for women in the newborn stage, like pregnancy and childbirth. All of these dangers need to be considered when making health decisions related to pregnant women, especially when developing a vaccine strategy.

At the moment, there is not much information about the effect of Covid-19 on pregnant women and their children, but we know some things. The association of viruses in the early stages of pregnancy does not add much to the possibility of miscarriage. The transmission of the virus from mother to baby in the womb is comparatively rare and children rarely fall ill.

One researcher says that the research will help vaccine manufacturers realize the importance of studying pregnant and lactating women and involving them in human trials. Research also suggests a possible difference between immune response from Pfizer vaccine to Moderna vaccine.